Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-029723
Filing Date
2025-09-23
Accepted
2025-09-23 16:06:49
Documents
116
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K aytu20250630c_10k.htm   iXBRL 10-K 2312538
2 EXHIBIT 10.24 ex_848258.htm EX-10.24 244595
3 EXHIBIT 21.1 ex_820735.htm EX-21.1 5036
4 EXHIBIT 23.1 ex_820736.htm EX-23.1 2495
5 EXHIBIT 31.1 ex_820737.htm EX-31.1 13802
6 EXHIBIT 31.2 ex_820738.htm EX-31.2 13812
7 EXHIBIT 32.1 ex_820739.htm EX-32.1 8404
13 aytu20250630c_10kimg001.jpg GRAPHIC 2559
  Complete submission text file 0001437749-25-029723.txt   12493479

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA aytu-20250630.xsd EX-101.SCH 111217
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aytu-20250630_cal.xml EX-101.CAL 86433
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aytu-20250630_def.xml EX-101.DEF 717580
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20250630_lab.xml EX-101.LAB 654007
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20250630_pre.xml EX-101.PRE 781596
119 EXTRACTED XBRL INSTANCE DOCUMENT aytu20250630c_10k_htm.xml XML 2139317
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-38247 | Film No.: 251333690
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)